Navigation Links
MegaMatcher and VeriFinger SDK Fingerprint Compression Algorithms Receive WSQ Certification from FBI Biometric Center of Excellence
Date:7/28/2011

VILNIUS, Lithuania, July 28, 2011 /PRNewswire/ -- Neurotechnology, a provider of high-precision biometric identification technologies, today announced that MegaMatcher and VeriFinger SDK fingerprint compression algorithms have received WSQ Certification. This means that the FBI has certified that these implementations meet the accuracy requirements in the Wavelet Scalar Quantization (WSQ) Gray-Scale Fingerprint Image Compression Specification, Version 3.1. Neurotechnology is among the first companies to receive FBI certifications for Version 3.1 of the WSQ, which is the latest standard for exchange of fingerprint images within the biometrics and criminal justice community. According to the FBI, the certification program is designed to facilitate interoperability between agencies and ensure efficient access to FBI criminal justice information services. Also WSQ certification is required by customers in many other countries and is included in various national-scale AFIS tender requirements. Neurotechnology has received a total of seven FBI WSQ certificates for different platform implementations, certifying that WSQ compression technology in MegaMatcher and VeriFinger SDKs meet FBI standards.

"Interoperability and biometric standards support is a critical requirement for large-scale biometric applications," said Irmantas Naujikas, business development director for Neurotechnology. "At Neurotechnology we are continuously working in this area and WSQ 3.1 certification by the FBI acknowledges our efforts. Having a product certified for all major PC platforms is very big competitive advantage for our customers."

The WSQ Specification sets the standard for the exchange of 8-bit, 500ppi fingerprint images by defining a class of encoders and a decoder that is capable of decoding compressed image data from any compliant encoder. To obtain the certification, a WSQ encoder and decoder must meet specific parameters and implement the full range of functionality required by the WSQ Specification. Compliance is determined by comparing the tested implementation with output from a "double precision reference implementation" developed at the National Institute of Standards and Technology (NIST).

In addition to the FBI WSQ Certification, the fingerprint algorithms in VeriFinger and MegaMatcher are NIST MINEX-compliant, making them suitable for use in US Government Personal Identity Verification program fingerprint recognition applications. Neurotechnology's fingerprint algorithms have won numerous Fingerprint Verification Competition (FVC) awards since 2000 for their high accuracy and reliability.

VeriFinger fingerprint identification technology is available as a software development kit (SDK) for the development of PC- and Web-based biometric solutions. More than 1500 end-user product brands in more than 100 countries have used the VeriFinger algorithm over the past 12 years.

MegaMatcher SDK incorporates the VeriFinger fingerprint algorithm in a more powerful, multi-biometric SDK that is suitable for large-scale AFIS solutions. In addition to the fingerprint identification technology, MegaMatcher also incorporates VeriLook (facial), VeriEye (iris), VeriSpeak (voice identification) and palmprint technologies – any of which can be used singularly or in any combination for development of fast, highly reliable multi-biometric solutions. Both VeriFinger and MegaMatcher support Microsoft Windows, Linux and Mac OSX platforms.

VeriFinger SDK and MegaMatcher SDK are available through Neurotechnology or from distributors worldwide. For more information, go to: http://www.Neurotechnology.com.

About Neurotechnology

Neurotechnology is a provider of high-precision biometric fingerprint, face, iris, palmprint and voice identification algorithms, object recognition technology and software development products. More than 2500 system integrators, security companies and hardware providers integrate Neurotechnology's algorithms into their products, with millions of customer installations worldwide.

Neurotechnology's identification algorithms have consistently earned the highest honors in some of the industry's most rigorous competitions, including the National Institute of Standards and Technology (NIST)'s Fingerprint Vendor Technology Evaluation (FpVTE) and IREX and the Fingerprint Verification Competitions (FVC).

Drawing from years of academic research in the fields of neuroinformatics, image processing and pattern recognition, Neurotechnology was founded in 1990 in Vilnius, Lithuania and released its first fingerprint identification system in 1991. Since that time the company has released more than 60 products and version upgrades for identification and verification of objects and personal identity.

Media Contact:
Jennifer Allen Newton
Bluehouse Consulting Group, Inc.
+1-503-805-7540
Jennifer (at) bluehousecg (dot) com


'/>"/>
SOURCE Neurotechnology
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Bangladesh Voter Registration Project Now Using MegaMatcher Biometric Technology to Detect and Prevent Duplicate Registrations
2. New MegaMatcher Accelerator Boosts Speed for High-Volume Biometric Identification and Database Duplicate Searching
3. Indonesia Now Using MegaMatcher Biometric Technology in Integrated Passport Issuance System
4. New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available
5. MegaMatcher Accelerator 3.0 for Rapid Biometric Identification Matches Up to 200 Million Irises or 100 Million Fingerprints Per Second
6. New MegaMatcher 4.0 from Neurotechnology Integrates Fingerprint, Iris, Facial and Palmprint Biometrics In One High-Performance SDK
7. New MegaMatcher 4.0 from Neurotechnology Integrates Fingerprint, Iris, Facial and Palmprint Biometrics In One High-Performance SDK
8. ID Solutions Achieves Full-Production Delivery and Payment for Fingerprint Processing Software for TWIC
9. Kount Receives Patent for Device Fingerprinting
10. Fingerprinting method tracks mercury emissions from coal
11. Frost & Sullivan Recognizes Precise Biometrics as a Key Player in the Non-AFIS Fingerprint Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/14/2017)... N.C. , Feb. 14, 2017  Wake Forest ... M.D., as its new chief executive officer (CEO). Freischlag ... CEO John D. McConnell , M.D., who last ... position at the Medical Center, after leading it since ... the full scope of Wake Forest Baptist,s academic health ...
(Date:2/10/2017)... Feb 10, 2017 Research and ... "Personalized Medicine - Scientific and Commercial Aspects" to ... ... Diagnosis is integrated with therapy for selection of treatment as ... detection and prevention of disease in modern medicine. Biochip/microarray technologies ...
(Date:2/8/2017)... BEDFORD, Mass., Feb. 7, 2017  Aware, Inc. (NASDAQ: ... services, today reported financial results for its quarter and year ... fourth quarter of 2016 was $3.9 million compared to $6.9 ... the fourth quarter of 2016 was $0.6 million compared to ... in the fourth quarter of 2016 was $0.5 million, or ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... Md. , March 23, 2017  Northwest ... developing DCVax® personalized immune therapies for solid tumor ... the $7.5 million financing it announced last Friday, ... sold to several institutional investors securities totaling 28,843,692 ... per share, and 10,000,000 shares of Class C ...
(Date:3/23/2017)...  BioPharmX Corporation (NYSE MKT: BPMX), a specialty ... today reported financial results for the quarter and ... an update on the company,s clinical development efforts ... are pleased to report that last year was ... Anja Krammer. "We achieved key clinical milestones and ...
(Date:3/23/2017)... -- NetworkNewsWire Editorial Coverage  ... Cancer remains one of the ... care systems, in terms of costs and resources. However, as ... development of innovative and efficient therapies that demonstrate higher chances ... of cancer treatments, a growing number of patients receiving immuno-oncology ...
(Date:3/23/2017)... -- In today,s pre-market research, Stock-Callers.com takes ... industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals Inc. ... Regulus Therapeutics Inc. (NASDAQ: RGLS ). On ... rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more about ... ...
Breaking Biology Technology: